DHHS → node
The U.S. Food and Drug Administration (FDA) reports that patients that use medications containing buprenorphine that are dissolved in the mouth may experience dental problems.
Dental problems, including tooth decay, cavities, oral infections and loss of teeth, can be serious and have been reported even in patients with no history of dental issues.
The U.S. Food and Drug Administration (FDA) reports that patients that use medications containing buprenorphine that are dissolved in the mouth may experience dental problems.
Dental problems, including tooth decay, cavities, oral infections and loss of teeth, can be serious and have been reported even in patients with no history of dental issues.
Effective February 21, 2022, no PA is needed for insulin used during pregnancy.
MaineCare will reimburse for Humulin and Novolin Neutral Protamine Hagedorn (NPH) insulin for pregnant patients without a PA when pregnancy is indicated on the prescription.
If you receive a denial of a prescription for Humulin or Novolin NPH insulin for prior authorization and pregnancy is indicated on the prescription, please contact the Change Healthcare Pharmacy Helpdesk at 1-888-420-9711 for a pregnancy override.
Effective February 21, 2022, no PA is needed for insulin used during pregnancy.
MaineCare will reimburse for Humulin and Novolin Neutral Protamine Hagedorn (NPH) insulin for pregnant patients without a PA when pregnancy is indicated on the prescription.
If you prescribe Humulin or Novolin NHP insulin to a patient who is pregnant, and the pharmacy refuses to fill the prescription or says that a PA is required, please call the Change Healthcare Provider Helpdesk at 1-888-420-9711.
Effective February 21, 2022, no PA is needed for insulin used during pregnancy.
The information below is archived information about the program.
The information below is archived information about the program.
We have updated the EVV FAQs with a new question.
We have updated the EVV FAQs with a new question.
Rate Update for 2022 Ambulatory Surgical Centers (ASC) Rates, CR 107519